Capital Raising

OPEN

Extracta

Creating value from recycled food by-products

INDUSTRY

Manufacturing

RAISING

A$2.5M

PRE-MONEY VALUATION

A$9.5M

OFFER PRICE

A$1.21

MINIMUM INVESTMENT

A$25,000

Investment Highlights


Sales contracts established with Australian and USA customers

Manufacturing facility established and operating

Two Australian government grants secured > $3 M and a third grant approved (to re-establish an Australian Pectin supply capability)

Extracta IP being extended with help from Macquarie Uni and QUT

Product Margins for Australian sales ( 70 – 90 %) – US sales (50 – 70%)

Company Overview


Extracta Produces nutrient rich ingredients for global markets

Customers include Food, Health Supplements and Cosmetic Manufacturers

Customers established in Australia and USA – agents in the UK / EU

Low-cost raw materials are extracted from farming waste streams

Lightning

Factory completed and operating

Strongly supported by the Australian Federal Government funding from 3 grants

company-overview-icon

Novel operating model is part of Extracta IP as is:

  • New Product development (Macquarie Uni as a partner)
  • New Process IP (Queensland University of Technology as a partner)

Investing in the circular economy

Extracta converts low-cost raw materials that are currently lost to the food chain into high-value products that have well established and growing consumer demand.

Extracta recovers waste streams and upcycles them into ingredients used by the food, nutraceutical and cosmetic industries - markets that are growing rapidly globally.

Environmentally aware production

Following environmentally responsible processing, which is increasingly demanded by customers, Extracta reduces other people’s waste, including reducing greenhouse gas emissions. This business model has resulted in the government awarding Extracta with 3 large funding grants.

There is increasing demand from Australian and also USA food manufacturers for these products, and a strong preference for local, reliable producers like Extracta.

Low volume, high margin

Extracta’s business model allows cost effective production of a wide range of seasonal fruits and vegetables.
 
Extracta has limited direct competitors in Australia because its business model is focused on locally made high margins and superior quality products.

For example pectin which has not been manufactured in Australia for 30 years there are no Australian Made competitors.

Australia has very few ingredient manufacturers for high-quality food and Food as Medicine market. For example, Extracta’s first customer MediKane was importing sugarcane from Japan as no competitive supplier exists in Australia, and now Extracta has demonstrated it can deliver top-quality ingredients at competitive prices.

Webinar Presentation

Transaction Overview


Raising A$2.5M

The full investment will purchase 23 percent of Extracta Pty Ltd stock with fully paid ordinary shares offered at A$1.21 per share.

This is a Series A Round only open to Sophisticated Investors. For significant investments that carry a strategic benefit, a board seat may be offered.

Working Capital Contingency

R&D Costs

Operations Costs

Sales Marketing Wages

14.5%
Fill Counter
15%
Fill Counter
31%
Fill Counter
39.5%
Fill Counter

Additional Information


Other Documents

General Disclaimer

The content on this site is provided solely for information purposes, is not a recommendation or an offer to buy or sell a security and is not warranted to be correct, complete or accurate. This site is intended for Accredited/Sophisticated/Wholesale investors only. By continuing with an investment, you are self-accrediting that you so qualify. To the extent permitted by law, neither PrimaryMarkets, its affiliates, nor the content providers (such as the issuers of securities who appear on the site) are responsible for any investment decisions, damages or losses resulting from, or related to, the content, data and analyses or their use. The investment opportunities on this site and any statements made about them by their issuers are not vetted or verified by PrimaryMarkets. Investing in securities in private or unlisted companies and Funds is speculative and involves a high degree of risk. The investor must be prepared to withstand a total loss of their investment. We strongly encourage the investor to seek independent financial, professional or investment advice before investing in securities. The presence of an investment opportunities on this site should not be interpreted as an implied endorsement of it by PrimaryMarkets. Some content provided may constitute a summary or extract of another document. Past performance does not necessarily indicate future performance. The content on this site was current as at date of initial publication but may not be current as at the date of your viewing. For a more complete understanding of all the terms and conditions of your use of this site click here.

Want to learn more?

Fill in the expression of interest form below